CME GroupCME -1.78%93 PEG Ratio is 1.71 as of Jun. 27, 2026, which is 51% below its 10-year median of 3.47. GuruFocus rates CME with a GF Score™ of 93/100 and a GF Value™ of $270.96 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 313 Capital Markets companies, CME Group ranks worse than 57.51% on this metric.
PE Ratio without NRI / 5-Year EBITDA Growth Rate*
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, CME Group's PE Ratio without NRI is 18.78. CME Group's 5-Year EBITDA growth rate is 11.00%. Therefore, CME Group's PEG Ratio for today is 1.71.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for CME Group's PEG Ratio or its related term are showing as below:
CME'
s PEG Ratio Range Over the Past 10 Years
Min: 1.62 Med: 3.47 Max: 96
Current: 1.71
During the past 13 years, CME Group's highest PEG Ratio was 96.00. The lowest was 1.62. And the median was 3.47.
CME's PEG Ratio is ranked worse than 57.51% of 313
companies
in the Capital Markets industry
Industry Median: 1.44
vs CME: 1.71
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
CME Group (NAS:CME) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
CME Group PEG Ratio Related Terms
CME Group PEG Ratio Historical Data
* Premium members only.
The historical data trend for CME Group's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Financial Data & Stock Exchanges subindustry, CME Group's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CME Group PEG Ratio vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, CME Group's PEG Ratio distribution charts can be found below:
* The bar in red indicates where CME Group's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
CME Group (CME) has a PEG Ratio of 1.71 as of Jun. 27, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on CME Group and its competitors. This is 51% below median its historical median of 3.47. Over the past decade, CME Group's PEG Ratio has ranged from 1.62 to 96.00. According to the industry distribution chart, CME Group ranks #180 out of 313 companies in the Capital Markets industry, placing it in the top 57.5%.
Is CME Group's PEG Ratio too high?
CME Group's current PEG Ratio of 1.71 is 51% below median its 10-year median of 3.47. Over the past 10 years, this metric has ranged from a low of 1.62 to a high of 96.00. The Capital Markets industry median PEG Ratio is 1.44. CME Group's value of 1.71 is 18.8% above this industry median. Based on the distribution chart, CME Group ranks #180 out of 313 companies in the Capital Markets industry, which is below the industry midpoint. Overall, CME Group has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CME Group's PEG Ratio compare to ICE and MCO?
According to the Capital Markets industry distribution chart, CME Group ranks #180 out of 313 companies for PEG Ratio. This places CME Group in the lower half of its industry. The industry median PEG Ratio is 1.44. CME Group's value of 1.71 is 18.8% above this benchmark. Historically, CME Group's own PEG Ratio has ranged from 1.62 to 96.00 over the past decade. While the company's 10-year median is 3.47 vs. the industry median of 1.44, CME Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Capital Markets company?
The median PEG Ratio among Capital Markets companies is 1.44, based on 313 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CME Group's current PEG Ratio of 1.71 is 18.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on CME Group and its competitors. For the Capital Markets industry, the median PEG Ratio is 1.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CME Group's current PEG Ratio is 1.71, which is 51% below median its own 10-year median of 3.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (CME) is currently considered Modestly Undervalued. The stock's GF Value™ is $270.96, compared to a current price of $221.00 — trading 18.4% below its estimated fair value. The current PEG Ratio is 1.71, which is 51% below median its 10-year median of 3.47 and 18.8% above the Capital Markets industry median of 1.44. CME Group's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For CME Group (CME), the current PEG Ratio is 1.71 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CME Group (CME) Overvalued in 2026?
Based on GuruFocus' analysis, CME Group stock appears to be undervalued.
The current stock price of $221.00 is trading 18.4% below its estimated GF Value™ of $270.96.
GuruFocus considers CME Group to be Modestly Undervalued.
Key valuation signals for CME:
PEG Ratio: 1.71 (51% below median its 10-year median of 3.47)
GF Value™: $270.96 vs. price of $221.00 (18.4% below fair value)
Industry Position: 18.8% above the Capital Markets median (#180 of 313)
No single metric tells the full story. See the CME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
93GF Score
Get the complete analysis for CME
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CME has been successfully added to your 
